Literature DB >> 25113848

Identification of germinal centres in the lymph node of a patient with hyperimmunoglobulin M syndrome associated with congenital rubella.

Rohan Ameratunga1, Chun-Jen J Chen, Wikke Koopmans, P Rod Dunbar, Maia Brewerton, Richard Lloydd, Claudia J Mansell, Chris van Vliet, See-Tarn Woon.   

Abstract

BACKGROUND: The hyper immunoglobulin M syndrome (HIM) associated with congenital rubella infection (rHIM) is an extremely rare disorder, where patients have elevated serum IgM in association with reduced IgG and IgA. We have previously shown that in contrast to X-linked HIM (XHIM), a patient with well-characterised rHIM is able to express functional CD40 ligand, undergo immunoglobulin isotype switching and to generate memory B cells. Here we describe the ultrastructural features of an excised lymph node from this patient.
METHODS: An inguinal lymph node was surgically removed and examined histologically as well as by immunohistochemistry. It was then stained with multiple fluorescent dyes to visualize the cellular interactions within the node. Flow cytometry was undertaken on a cellular suspension from the node.
FINDINGS: Our patient has normal lymph node architecture by light microscopy. Immunohistochemistry studies showed the presence of scattered germinal centres. Polychromatic immunofluorescence staining showed disruption of the architecture with mostly abnormal germinal centres. A small number of relatively intact germinal centres were identified. Both IgM and IgG bearing cells were identified in germinal centres.
INTERPRETATION: In contrast to XHIM where germinal centres are absent, the presence of small numbers of relatively normal germinal centres explain our previous identification of isotype switched memory B cells in rHIM.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25113848     DOI: 10.1007/s10875-014-0084-6

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  34 in total

1.  The evidence for the elimination of rubella and congenital rubella syndrome in the United States: a public health achievement.

Authors:  Susan E Reef; Stephen L Cochi
Journal:  Clin Infect Dis       Date:  2006-11-01       Impact factor: 9.079

2.  Congenital rubella syndrome. Lymphoid tissue and immunologic status.

Authors:  D B Singer; M A South; J R Montgomery; W E Rawls
Journal:  Am J Dis Child       Date:  1969-07

3.  Progress toward control of rubella and prevention of congenital rubella syndrome--worldwide, 2009.

Authors:  S E Reef; P Strebel; A Dabbagh; M Gacic-Dobo; S Cochi
Journal:  J Infect Dis       Date:  2011-07       Impact factor: 5.226

Review 4.  Burden of Congenital Rubella Syndrome (CRS) in India: a systematic review.

Authors:  Pooja Dewan; Piyush Gupta
Journal:  Indian Pediatr       Date:  2012-05       Impact factor: 1.411

5.  Clinical utility of a lymph node normal range obtained by flow cytometry.

Authors:  C F Bryan; P J Eastman; J B Conner; K A Baier; J B Durham
Journal:  Ann N Y Acad Sci       Date:  1993-03-20       Impact factor: 5.691

Review 6.  Rubella virus and birth defects: molecular insights into the viral teratogenesis at the cellular level.

Authors:  C D Atreya; K V K Mohan; S Kulkarni
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2004-07

7.  Congenital rubella syndrome, hyper-IgM syndrome and autoimmunity in an 18-year-old girl.

Authors:  Pere Soler Palacin; Yolanda Castilla; Paula Garzón; Concepció Figueras; Joan Castellví; Teresa Español
Journal:  J Paediatr Child Health       Date:  2007-10       Impact factor: 1.954

8.  Impaired cell-mediated immune response in patients with congenital rubella: correlation with gestational age at time of infection.

Authors:  E Buimovici-Klein; P B Lang; P R Ziring; L Z Cooper
Journal:  Pediatrics       Date:  1979-11       Impact factor: 7.124

Review 9.  Rubella.

Authors:  J E Banatvala; D W G Brown
Journal:  Lancet       Date:  2004-04-03       Impact factor: 79.321

10.  Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the Hyper-IgM syndrome (HIGM2).

Authors:  P Revy; T Muto; Y Levy; F Geissmann; A Plebani; O Sanal; N Catalan; M Forveille; R Dufourcq-Labelouse; A Gennery; I Tezcan; F Ersoy; H Kayserili; A G Ugazio; N Brousse; M Muramatsu; L D Notarangelo; K Kinoshita; T Honjo; A Fischer; A Durandy
Journal:  Cell       Date:  2000-09-01       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.